Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
I MONITORIZAREA
OXIGENOTERAPIEI N BOLILE
PULMONARE
Ramona Miron, Mihaela Sandu, A.Trofor, T.
Mihescu
Spital Clinic de Pneumoftiziologie Iai
INTRODUCERE
http://www.ers-education.org/pages/default.aspx?id=335&idBrowse=47886&det=1
Indications for oxygen treatment in advanced COPD - postgraduate course ERS 2008
Indicaiile general acceptate ale
oxigenoterapiei de lung durat (OLD)
AARC Clinical Practice Guideline
Oxygen Therapy in the Home or Alternate Site Health Care Facility 2007 Revision & Update
Mucoviscidoza
Bolile restrictive IC n stadii terminale
(alveolita fibrozant sau Cancere pulmonare n faze avansate
pneumoconioza) Boli pulmonare obstructive sau
fibrozante n stadii terminale (O2
reduce dispneea i fatigabilitatea)
AARC Clinical Practice Guideline Oxygen Therapy for Adults in the Acute Care Facility 2002
Oxigenoterapia n ambulator
Clinical component for the home oxygen service in England and Wales, the British Thoracic Society (BTS) Working
Group on Home Oxygen Services, London, UK: Department of Health, 2006.
Oxigenoterapia exacerbri BPOC
Sea level SpO2 92-95% and no risk factor* Oxygen not required (C)
Sea level SpO2 92-95% and additional risk factor* Perform hypoxic challenge test
with arterial or capillary
measurements (B)
Durata:
Uneori continuu
o are 25 de kg
M.J. Kampelmacher, Administration and monitoring of oxygen therapy, The buyers guide 2010 to respiratory care products
Avantaje
concentratoarele de oxigen
sigure , ieftine
uor de manipulat pentru c nu necesit
rencrcare,
reglare uoar de la debitmetru
concentratorul este dotat cu rotie pentru a se
deplasa uor prin ncpere
nu necesit reductor de presiune
Presiunea este sub o atmosfera fa de tuburile
de oxigen la care presiunea este de 150 de
atmosfere
M.J. Kampelmacher, Administration and monitoring of oxygen therapy, The buyers guide 2010 to respiratory care products
Dezavantaje
concentratoarele de O2
M.J. Kampelmacher, Administration and monitoring of oxygen therapy, The buyers guide 2010 to respiratory care products
Cilindri de oxigen gazos
M.J. Kampelmacher, Administration and monitoring of oxygen therapy, The buyers guide 2010 to respiratory care products
Dispozitive de economisire a oxigenului
http://www.bocvitalair.co.uk/vitalair/clinicians/ocd_clinicians.asp?
tabno=3&tabid=sc3
Dezavantaje - buteliile de oxigen
M.J. Kampelmacher, Administration and monitoring of oxygen therapy, The buyers guide 2010 to respiratory care products
Avantaje - oxigen lichid
Este silenios
Autonomia este prelungit
Comprimarea unei cantiti mari de O2
ntr-un spaiu mic
Dac este umplut de pacient autonomia
este de 6-7 ore
Este portabil i are greutate mic
M.J. Kampelmacher, Administration and monitoring of oxygen therapy, The buyers guide 2010 to respiratory care products
Dezavantaje - oxigen lichid
Costurile mari
M.J. Kampelmacher, Administration and monitoring of oxygen therapy, The buyers guide 2010 to respiratory care products
Tipuri de interfee utilizate
M.J. Kampelmacher, Administration and monitoring of oxygen therapy, The buyers guide 2010 to respiratory care products
The non rebreathing mask
Kampelmacher MJ, van Kesteren RG, Deenstra M, et al. Long-term oxygen therapy. Neth J Med 1994; 44: 141-152
The partial rebreathing mask (masca cu
reinhalare parial)
Kampelmacher MJ, van Kesteren RG, Deenstra M, et al. Long-term oxygen therapy. Neth J Med 1994; 44: 141-152
Thorax 2008;63(Suppl VI):vi1vi68. doi:10.1136/thx.2008.102947
Masca facial simpl
Catetere nazofaringiene-
mentinerea unei
concentratii crescute de
O2 inspirat
VICES FOR OXYGEN ADMINISTRATION IN PATIENTS WITH HYPOXAEMIA DURING SPONTANEOUS BREATHING J. Geiseler and O. Karg-
E BUYERS GUIDE TO RESPIRATORY CARE PRODUCTS 2009
Umidificarea oxigenului
Tehnici de monitorizare
Non-invazive
Invazive
PO2 capilar este totui cu 3.7-7.5 mm Hg (0.5-1.0 kPa) mai mic dect PO2
arterial, n special la PO2 > 60-75 mm Hg
http://www.patient.co.uk/doctor/Use-of-Oxygen-Therapy-in-COPD.htm
Zavorsky GS, Cao J, Mayo NE, et al. Arterial versus capillary blood gases: a meta-analysis. Respir Physiol Neurobiol 2007;
155:, 268279
Valori normale SaO2 i PaO2 n funcie
de vrst
Monitorizarea oxigenoterapiei
Reversia policitemiei
Ameliorarea hipertensiunii pulmonare
Ameliorarea funciei ventriculului stng i
drept
Creterea toleranei la efort
Corectarea hipoxemiei
Reducerea dispneii
Ameliorarea funciei cerebrale
Discuii
Suplimentarea cu oxigen este optim pt corectarea
hipoxemiei
Oxigenoterapia amelioreaz dispneea
Trebuie s avem un scop clar de prescriere:
mbuntirea supravieuirii
Reducerea dispneei
mbuntirea calitii vieii - permind activiti extradomiciliare
Prescrierea oxigenului
O evaluare atent n funcie de necesitile pacientului
Folosirea de tehnologie adecvat
Necesarul de oxigen se schimb n timp
http://www.erseducation.org/pages/default.aspx?id=335&idBrowse=47886&det=1 ERS 2008
CONCLUZII